How to Delete IBM Micromedex NeoFax. save (8.46 MB)
Published by Truven Health Analytics Inc.We have made it super easy to delete IBM Micromedex NeoFax account and/or app.
Table of Contents:
Guide to Delete IBM Micromedex NeoFax 👇
Things to note before removing IBM Micromedex NeoFax:
- The developer of IBM Micromedex NeoFax is Truven Health Analytics Inc. and all inquiries must go to them.
- Check the Terms of Services and/or Privacy policy of Truven Health Analytics Inc. to know if they support self-serve account deletion:
- The GDPR gives EU and UK residents a "right to erasure" meaning that you can request app developers like Truven Health Analytics Inc. to delete all your data it holds. Truven Health Analytics Inc. must comply within 1 month.
- The CCPA lets American residents request that Truven Health Analytics Inc. deletes your data or risk incurring a fine (upto $7,500 dollars).
↪️ Steps to delete IBM Micromedex NeoFax account:
1: Visit the IBM Micromedex NeoFax website directly Here →
2: Contact IBM Micromedex NeoFax Support/ Customer Service:
- 100% Contact Match
- Developer: Mobile Micromedex
- E-Mail: mdx.techsupp@us.ibm.com
- Website: Visit IBM Micromedex NeoFax Website
- 73.91% Contact Match
- Developer: Mobile Micromedex
- E-Mail: mdx.techsupp@us.ibm.com
- Website: Visit Mobile Micromedex Website
3: Check IBM Micromedex NeoFax's Terms/Privacy channels below for their data-deletion Email:
Deleting from Smartphone 📱
Delete on iPhone:
- On your homescreen, Tap and hold IBM Micromedex NeoFax until it starts shaking.
- Once it starts to shake, you'll see an X Mark at the top of the app icon.
- Click on that X to delete the IBM Micromedex NeoFax app.
Delete on Android:
- Open your GooglePlay app and goto the menu.
- Click "My Apps and Games" » then "Installed".
- Choose IBM Micromedex NeoFax, » then click "Uninstall".
Have a Problem with IBM Micromedex NeoFax? Report Issue
🎌 About IBM Micromedex NeoFax
1. Do you work at a facility that subscribes to IBM Micromedex NeoFax? Check with your Chief of Pediatrics, Director of Pediatrics, Director of the NICU, Directory of Pharmacy, Chief Medical Officer, Chief Nursing Officer, Medical Librarian, or anyone else at your facility responsible for clinical reference information.
2. IBM Micromedex NeoFax app is a reliable resource for on-the-go access to evidence-based drug information to efficiently and safely manage drug therapy for neonatal patients.
3. IBM Micromedex NeoFax drug information is intended for full-term babies up to 28 days of age (PNA) and preterm babies up to 44 weeks postmenstrual age (GA + PNA).
4. IBM Micromedex NeoFax is a trusted source for neonatal drug dosing, based on the strict editorial policies and practices that have guided IBM Micromedex NeoFax for more than 30 years.
5. The drug monographs cover information including: dose, administration, uses, contraindications/precautions, adverse effects, monitoring, pharmacology, special considerations/preparation, solution- and drug-drug compatibility/incompatibility information, and references.
6. If you work at a facility that subscribes to IBM Micromedex NeoFax, free access requires a password.
7. Evidence-based, fully referenced neonatal-specific drug information enables clinicians to make informed treatment decisions.
8. This mobile app also includes a comprehensive enteral formulas component providing nutritional information for approximately 60 different neonatal and infant formulas, and human milk fortifiers.
9. IBM Micromedex NeoFax app is free to subscribers of IBM Micromedex NeoFax online.
10. It allows clinicians to make accurate and more informed treatment decisions at the point of care, while minimizing errors in this vulnerable patient population.
11. An internet connection is not required, allowing you to make decisions with confidence at anytime, from anywhere.
12. Existing paid customers will continue to have access to the content going forward.
13. This neonatal-specific app has clinical value for doctors, nurses, and pharmacists.
